The University of Southampton
University of Southampton Institutional Repository

DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?

DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?
Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether β-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome.

Methods. This was a prospective, multinational pharmacokinetic point-prevalence study including 8 β-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f T>MIC) and 100% (100% f T>MIC) of the dosing interval. We used skewed logistic regression to describe the effect of antibiotic exposure on patient outcome.

Results. We included 384 patients (361 evaluable patients) across 68 hospitals. The median age was 61 (interquartile range [IQR], 48–73) years, the median Acute Physiology and Chronic Health Evaluation II score was 18 (IQR, 14–24), and 65% of patients were male. Of the 248 patients treated for infection, 16% did not achieve 50% f T>MIC and these patients were 32% less likely to have a positive clinical outcome (odds ratio [OR], 0.68; P = .009). Positive clinical outcome was associated with increasing 50% f T>MIC and 100% f T>MIC ratios (OR, 1.02 and 1.56, respectively; P < .03), with significant interaction with sickness severity status.

Conclusions. Infected critically ill patients may have adverse outcomes as a result of inadequate antibiotic exposure; a paradigm change to more personalized antibiotic dosing may be necessary to improve outcomes for these most seriously ill patients.
1058-4838
1072-1083
Roberts, J.A.
3ee5063c-bc8a-41c6-ae47-c56e4e31a927
Paul, S.K.
2b7adbf4-cc39-4da7-a7ca-cfb3e3c7c27d
Akova, M.
4b98aac5-05ee-4265-81df-55909b4747ac
Bassetti, M.
69989d46-a7bf-4230-adbe-f2320d1a0202
De Waele, J.J.
c6b5c72e-cac7-451b-bb98-9d1a1ba1f8ca
Dimopoulos, G.
388a060e-faae-48d3-9533-3ac4d5825cab
Kaukonen, K.-M.
bcf8788f-679a-48e1-84a8-231c01c84fbf
Koulenti, D.
2ac3d761-49e2-4927-bdaa-f75f75d43cf5
Martin, C.
f999e45c-c83b-4658-a9ea-a7610518ec13
Montravers, P.
eef1e2db-fdf1-4c29-a0c1-f143f5e1776b
Rello, J.
abad1dd1-6169-46d6-b477-823d66d98ccc
Rhodes, A.
f3418b79-08bb-4669-ba30-5e3b87419299
Starr, T.
89636156-3485-47d7-99c7-6e0e1ebc6253
Wallis, S.C.
2bd0fc55-8e8e-4996-9810-6f5f9716b92a
Lipman, J.
065a91d6-6087-48a6-9088-31a590c23dcc
Margarit Ribas, A.
494b804b-65fb-4c53-af4d-06a4e08aee8e
De Crop, L.
bd442666-728a-41d4-a6a8-601c5cfbaab1
Spapen, H.
e4889fb7-315e-4a76-ade6-95ca2a8f7b37
Wauters, J.
fd30948e-0a92-47c1-b568-e15d4ac2a09e
Dugernier, T.
033f0f05-75af-4beb-bfcf-030863802db0
Jorens, P.
2108b64a-c647-4267-a6e2-a03b439b07d4
Dapper, I.
6592cc36-72fd-4002-be16-a201a9d12641
De Backer, D.
d9773fee-371c-4148-8c35-dd21ba4db08e
Taccone, F.S.
d5bc5d9e-da19-4615-970e-7a88f0101d6e
Ruano, L.
5cc5ecc3-79b8-4224-b33a-718516f5407c
Afonso, E.
5360743b-8b8a-40af-8f03-4ca62d903636
Alvarez-Lerma, F.
a31a1d43-07e4-4584-ad5e-f491cca02543
Gracia-Arnillas, M.P.
ad4fa379-363b-4c6b-8f32-1483f5bdfacd
Fernández, F.
6f8d2bc7-221b-49f5-900d-69a091d2f4b6
Feijoo, N.
419e8eca-89f9-4ec5-9581-d8c7220191d5
Bardolet, N.
98ecfd93-68d8-419c-a4c4-73d8951e45b4
Rovira, A.
808cc7a7-ce25-4d26-a3a6-7fd9ac45d2c7
Garro, P.
7569b0e1-c95c-427e-9a86-efc3909d37ae
Colon, D.
17540d63-6e99-4477-9a6b-0854d0342412
Castillo, C.
cfdf4438-0c3f-421c-a4c3-f96719e744cb
Fernado, J.
063345ea-145a-404c-a112-f961559a7af1
Lopez, M.J.
59005a66-002c-4446-af37-a120bf605885
Fernandez, J.L.
7dfada4c-c61d-4429-a72a-0a878dbccf6a
Arribas, A.M.
d84cdb1c-c80b-4fa1-95d3-10e7a33fad38
Teja, J.L.
ff920a56-15f2-44a9-a6b1-3b41720c1ddd
Ots, E.
43c3609d-ff07-4a6f-a4e1-57610723b213
Carlos Montejo, J.
a2d71381-ae9d-4ff0-b2aa-37f5f8ac0264
Catalan, M.
13b78ceb-cd4f-4b74-9d02-5d6986b3154a
Prieto, I.
4d3ccaff-8f2a-48de-9440-81ec7050e06a
Gonzalo, G.
d446da3e-fb3b-433f-8c8f-65a0c4878540
Galvan, B.
81d9ea98-1545-4c74-8f3d-64c6022472f2
Blasco, M.A.
ac2b80c5-5484-4702-b901-1ba98e4ce7da
Meyer, E.
b18c8b89-6a81-4b95-a342-2ab54b48ac39
Del Nogal, F.
1ae21d3f-e88a-409e-a638-d012f21b46cf
McKenzie, C.
ec344dee-5777-49c5-970e-6326e82c9f8c
DALI Authors
Roberts, J.A.
3ee5063c-bc8a-41c6-ae47-c56e4e31a927
Paul, S.K.
2b7adbf4-cc39-4da7-a7ca-cfb3e3c7c27d
Akova, M.
4b98aac5-05ee-4265-81df-55909b4747ac
Bassetti, M.
69989d46-a7bf-4230-adbe-f2320d1a0202
De Waele, J.J.
c6b5c72e-cac7-451b-bb98-9d1a1ba1f8ca
Dimopoulos, G.
388a060e-faae-48d3-9533-3ac4d5825cab
Kaukonen, K.-M.
bcf8788f-679a-48e1-84a8-231c01c84fbf
Koulenti, D.
2ac3d761-49e2-4927-bdaa-f75f75d43cf5
Martin, C.
f999e45c-c83b-4658-a9ea-a7610518ec13
Montravers, P.
eef1e2db-fdf1-4c29-a0c1-f143f5e1776b
Rello, J.
abad1dd1-6169-46d6-b477-823d66d98ccc
Rhodes, A.
f3418b79-08bb-4669-ba30-5e3b87419299
Starr, T.
89636156-3485-47d7-99c7-6e0e1ebc6253
Wallis, S.C.
2bd0fc55-8e8e-4996-9810-6f5f9716b92a
Lipman, J.
065a91d6-6087-48a6-9088-31a590c23dcc
Margarit Ribas, A.
494b804b-65fb-4c53-af4d-06a4e08aee8e
De Crop, L.
bd442666-728a-41d4-a6a8-601c5cfbaab1
Spapen, H.
e4889fb7-315e-4a76-ade6-95ca2a8f7b37
Wauters, J.
fd30948e-0a92-47c1-b568-e15d4ac2a09e
Dugernier, T.
033f0f05-75af-4beb-bfcf-030863802db0
Jorens, P.
2108b64a-c647-4267-a6e2-a03b439b07d4
Dapper, I.
6592cc36-72fd-4002-be16-a201a9d12641
De Backer, D.
d9773fee-371c-4148-8c35-dd21ba4db08e
Taccone, F.S.
d5bc5d9e-da19-4615-970e-7a88f0101d6e
Ruano, L.
5cc5ecc3-79b8-4224-b33a-718516f5407c
Afonso, E.
5360743b-8b8a-40af-8f03-4ca62d903636
Alvarez-Lerma, F.
a31a1d43-07e4-4584-ad5e-f491cca02543
Gracia-Arnillas, M.P.
ad4fa379-363b-4c6b-8f32-1483f5bdfacd
Fernández, F.
6f8d2bc7-221b-49f5-900d-69a091d2f4b6
Feijoo, N.
419e8eca-89f9-4ec5-9581-d8c7220191d5
Bardolet, N.
98ecfd93-68d8-419c-a4c4-73d8951e45b4
Rovira, A.
808cc7a7-ce25-4d26-a3a6-7fd9ac45d2c7
Garro, P.
7569b0e1-c95c-427e-9a86-efc3909d37ae
Colon, D.
17540d63-6e99-4477-9a6b-0854d0342412
Castillo, C.
cfdf4438-0c3f-421c-a4c3-f96719e744cb
Fernado, J.
063345ea-145a-404c-a112-f961559a7af1
Lopez, M.J.
59005a66-002c-4446-af37-a120bf605885
Fernandez, J.L.
7dfada4c-c61d-4429-a72a-0a878dbccf6a
Arribas, A.M.
d84cdb1c-c80b-4fa1-95d3-10e7a33fad38
Teja, J.L.
ff920a56-15f2-44a9-a6b1-3b41720c1ddd
Ots, E.
43c3609d-ff07-4a6f-a4e1-57610723b213
Carlos Montejo, J.
a2d71381-ae9d-4ff0-b2aa-37f5f8ac0264
Catalan, M.
13b78ceb-cd4f-4b74-9d02-5d6986b3154a
Prieto, I.
4d3ccaff-8f2a-48de-9440-81ec7050e06a
Gonzalo, G.
d446da3e-fb3b-433f-8c8f-65a0c4878540
Galvan, B.
81d9ea98-1545-4c74-8f3d-64c6022472f2
Blasco, M.A.
ac2b80c5-5484-4702-b901-1ba98e4ce7da
Meyer, E.
b18c8b89-6a81-4b95-a342-2ab54b48ac39
Del Nogal, F.
1ae21d3f-e88a-409e-a638-d012f21b46cf
McKenzie, C.
ec344dee-5777-49c5-970e-6326e82c9f8c

Roberts, J.A., Paul, S.K. and Akova, M. , DALI Authors (2014) DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? Clinical Infectious Diseases, 58 (8), 1072-1083. (doi:10.1093/cid/ciu027).

Record type: Article

Abstract

Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether β-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome.

Methods. This was a prospective, multinational pharmacokinetic point-prevalence study including 8 β-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f T>MIC) and 100% (100% f T>MIC) of the dosing interval. We used skewed logistic regression to describe the effect of antibiotic exposure on patient outcome.

Results. We included 384 patients (361 evaluable patients) across 68 hospitals. The median age was 61 (interquartile range [IQR], 48–73) years, the median Acute Physiology and Chronic Health Evaluation II score was 18 (IQR, 14–24), and 65% of patients were male. Of the 248 patients treated for infection, 16% did not achieve 50% f T>MIC and these patients were 32% less likely to have a positive clinical outcome (odds ratio [OR], 0.68; P = .009). Positive clinical outcome was associated with increasing 50% f T>MIC and 100% f T>MIC ratios (OR, 1.02 and 1.56, respectively; P < .03), with significant interaction with sickness severity status.

Conclusions. Infected critically ill patients may have adverse outcomes as a result of inadequate antibiotic exposure; a paradigm change to more personalized antibiotic dosing may be necessary to improve outcomes for these most seriously ill patients.

This record has no associated files available for download.

More information

Accepted/In Press date: 10 October 2013
e-pub ahead of print date: 14 January 2014
Published date: 15 April 2014

Identifiers

Local EPrints ID: 479370
URI: http://eprints.soton.ac.uk/id/eprint/479370
ISSN: 1058-4838
PURE UUID: ea5b03f4-c18b-4d34-9fb4-d8161d1689b9
ORCID for C. McKenzie: ORCID iD orcid.org/0000-0002-5190-9711

Catalogue record

Date deposited: 20 Jul 2023 17:37
Last modified: 17 Mar 2024 04:23

Export record

Altmetrics

Contributors

Author: J.A. Roberts
Author: S.K. Paul
Author: M. Akova
Author: M. Bassetti
Author: J.J. De Waele
Author: G. Dimopoulos
Author: K.-M. Kaukonen
Author: D. Koulenti
Author: C. Martin
Author: P. Montravers
Author: J. Rello
Author: A. Rhodes
Author: T. Starr
Author: S.C. Wallis
Author: J. Lipman
Author: A. Margarit Ribas
Author: L. De Crop
Author: H. Spapen
Author: J. Wauters
Author: T. Dugernier
Author: P. Jorens
Author: I. Dapper
Author: D. De Backer
Author: F.S. Taccone
Author: L. Ruano
Author: E. Afonso
Author: F. Alvarez-Lerma
Author: M.P. Gracia-Arnillas
Author: F. Fernández
Author: N. Feijoo
Author: N. Bardolet
Author: A. Rovira
Author: P. Garro
Author: D. Colon
Author: C. Castillo
Author: J. Fernado
Author: M.J. Lopez
Author: J.L. Fernandez
Author: A.M. Arribas
Author: J.L. Teja
Author: E. Ots
Author: J. Carlos Montejo
Author: M. Catalan
Author: I. Prieto
Author: G. Gonzalo
Author: B. Galvan
Author: M.A. Blasco
Author: E. Meyer
Author: F. Del Nogal
Author: C. McKenzie ORCID iD
Corporate Author: DALI Authors

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×